Bariatric surgery for fatty liver disease in people with obesity
Part of Digestive system, Hormones & metabolism clinical trials.
This trial looks at whether weight-loss (bariatric) surgery helps people with fatty liver disease, including “NASH,” and related liver scarring. If you have obesity and a confirmed liver fat diagnosis (and for NASH, biopsy-proven NASH with some fibrosis), the study may follow your outcomes after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 16 to 65, any sex.
- You have obesity (based on Asian body-weight standards) and are planning your first bariatric surgery at the study hospital.
- Your liver fat problem is confirmed before surgery by imaging (ultrasound or MRI fat measurements) or by liver tissue taken during surgery.
- For the “NASH” part: you have biopsy-proven NASH with early scarring (at least stage F1 fibrosis).
- You have not had bariatric surgery before.
- You can understand the study and are willing to sign consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure called bariatric embolization, which uses tiny particles to block blood flow to part of the stomach, to help you lose weight and reduce liver inflammation from NASH. It might be an option if you have NASH and have not been able to lose weight with diet and exercise alone.
This trial tests whether a very low calorie ketogenic diet (a strict low-carb, high-fat diet) can help people with non-alcoholic steatohepatitis (NASH) who have liver scarring. Participants will follow this diet for a year and have two liver biopsies to see if their liver health improves.
This study uses multiple types of health data (“multi-omics”) to help choose a personalized treatment plan for people with obesity-related fatty liver disease. It may help match treatment to your biology to improve outcomes.
This study tests whether bariatric surgery (either sleeve gastrectomy or Roux-en-Y gastric bypass) improves severe nonalcoholic steatohepatitis (NASH) with advanced liver scarring in people who are obese. You may also need liver biopsies to confirm your liver disease before and after treatment.
This study looks at how fatty liver disease may predict future liver health in people with severe weight gain. It compares people who are planning bariatric (weight-loss) surgery with similar people who are not, to better understand who may be at higher risk.
This study tests a stomach bypass stent to treat liver scarring caused by fatty liver disease in people with obesity. If you have obesity and a confirmed liver condition called NASH with moderate scarring, this stent might help you achieve weight loss and improve your liver health.
Hear when a new Bariatric Surgery Candidate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.